![A Phase II Study of Gefitinib Monotherapy in Advanced Esophageal Adenocarcinoma: Evidence of Gene Expression, Cellular, and Clinical Response]()
A Phase II Study of Gefitinib Monotherapy in Advanced Esophageal Adenocarcinoma: Evidence of Gene Expression, Cellular, and Clinical ResponseFerry, D. R.; Anderson, M.; Beddard, K.; Tomlinson, S.; Atherfold, P.; Obszynska, J.; Harrison, R.; Jankowski, J. · Clinical Cancer Research · 2007